AssetMark Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18K | Buy |
60
+54
| +900% | +$1.96K | ﹤0.01% | 2403 |
|
|
2025
Q1 | $217 | Hold |
6
| – | – | ﹤0.01% | 2524 |
|
|
2024
Q4 | $252 | Buy |
+6
| New | +$252 | ﹤0.01% | 2459 |
|
|
2022
Q4 | – | Sell |
-18
| Closed | -$1K | – | 1647 |
|
|
2022
Q3 | $1K | Sell |
18
-4,522
| -100% | -$251K | ﹤0.01% | 1473 |
|
|
2022
Q2 | $271K | Buy |
4,540
+102
| +2% | +$6.09K | ﹤0.01% | 705 |
|
|
2022
Q1 | $322K | Buy |
4,438
+2,354
| +113% | +$171K | ﹤0.01% | 681 |
|
|
2021
Q4 | $175K | Buy |
2,084
+2,005
| +2,538% | +$168K | ﹤0.01% | 725 |
|
|
2021
Q3 | $7K | Buy |
+79
| New | +$7K | ﹤0.01% | 1098 |
|
|
2020
Q1 | – | Sell |
-31
| Closed | -$1K | – | 1506 |
|
|
2019
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 1332 |
|
|
2019
Q3 | $1K | Buy |
31
+18
| +138% | +$581 | ﹤0.01% | 1259 |
|
|
2019
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1263 |
|
|
2019
Q1 | $1K | Sell |
13
-1
| -7% | -$77 | ﹤0.01% | 1270 |
|
|
2018
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 1345 |
|
|
2018
Q1 | – | Sell |
-12
| Closed | -$1K | – | 1865 |
|
|
2017
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1682 |
|
|
2016
Q1 | – | Sell |
-5
| Closed | -$1K | – | 1363 |
|
|
2015
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1251 |
|